Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ILIV JV NEWS!! MERGER NEWS!!
http://online.wsj.com/article/PR-CO-20131104-905399.html?dsk=y
November 4, 2013, 9:05 a.m. ET
Intelligent Living Inc. Announces Joint Venture With Monster Arts, Inc. to Develop Mobile Applications
Email
Printer
Friendly
Share:
facebook ? More
smaller Text larger
Intelligent Living Inc. Announces Joint Venture With Monster Arts, Inc. to Develop Mobile Applications
ILIV and APPZ Enter Into Agreement to Collaborate on Mobile Software
MIAMI, FL and LOS ANGELES, CA--(Marketwired - Nov 4, 2013) - Intelligent Living Inc. (OTCQB: ILIV) announced today that it had entered into a multi-year deal with Monster Arts, Inc. (OTCQB: APPZ) for the development of mobile and web accessible games, mobile health (mHealth) and wellness and learning applications.
"We are very committed to building mobile and web based platforms for wellness, mHealth and cognitive learning. With brands such as MIND360, Intelligent Living and Health and Beyond, we see excellent opportunities for this company to position itself as a leader in the field of genre, brand-specific applications. APPZ has a lot of experience and expertise in game and mobile applications development, and we are excited about this partnership and collaboration," observed Josh Eikov, CSO of Intelligent Living.
According to VisionMobile's 2012 Developer Economics report, "The app economy was worth $53 billion and is expected to expand at a 28% Compounded Annual Growth Rate (CAGR) up to 2016, reaching $143 billion." A study commissioned by Telenor Group and the Boston Consulting Group in first quarter of 2012 revealed: 30% of smartphone users are likely to use "wellness apps" by 2015 and secondly, mobile is the most popular technology among doctors since the stethoscope. The survey further revealed costs in elderly care can be reduced by 25% while maternal and prenatal mortality expenses can be reduced by as much as 30% through mobile solutions. As per a recent PwC Global Healthcare survey, 59% of the consumers using mHealth services reported that these services have reduced the number of visits to the doctor. The increasing enthusiasm among smartphone armed consumers for medical apps has made service providers to include apps in their delivery mechanism and provide services through it.
"As a Company that has been very involved in the mobile market we know that mobile healthcare apps and learning games are booming in usage, both by consumers and health care providers, but it's early days yet for the consumer healthcare industry. There is a huge potential of mobile apps in patient care much beyond what we are witnessing today. We are very excited to be entering this arena and look forward to a great alliance with Intelligent Living," said Wayne Irving II, CEO of APPZ.
According to a PWC survey, 64% of doctors believe the mHealth market to be full of exciting possibilities in the days ahead. For consumers, evolution in healthcare apps means more control and better management of their health at lesser costs. In other words, mobile apps are set to occupy a dominant position across the ecosystem.
Eikov went on to explain, "The Joint Venture calls for the building of app stores, portals and use of iTunes, Google Play and Nook, Kindle and other platforms for distribution of nearly thousands of apps. The apps will be available according to genre: mHealth will be available under the Intelligent Living brand, wellness apps will be available under the Health and Beyond label, and MIND360 Studios publishing platform will have its own portal and app store for what will become the premiere mobile location for brain games, puzzles, cognitive games and edutainment."
Both companies expect products to start to become available mid-to-late December in time for the holiday season.
About Monster Arts, Inc.
Monster Arts is a leading mobile marketing and app technology innovator, designing a variety of mobile apps for purchase and download by the retail consumer, and assisting business clients with online marketing through its Travel America Visitor Guide, mobile app design services, crowd funding consulting services, and Daily Deal information management and analytics.
More information about Monster Arts can be found by visiting the company's website located at http://www.monsterarts.net/.
About Intelligent Living Inc.
Intelligent Living Inc. operates as a development stage company focused on the ever-expanding age management and wellness markets. Its markets include exercise, nutrition, supplements, mental acuity testing and training, through our newly acquired subsidiary MIND360, and hormone replacement therapy. The Company, based in Florida, is a health and wellness company engaged in the development of software and technology to aid in age management and cognitive health. The mission of Intelligent Living is to improve a person's quality and function of daily living over a span of many years.
More information about Intelligent Living can be found on the Company's website located at http://www.intelligentlivinginc.com
Forward Looking Statements
This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act") and as such, may involve risks and uncertainties. Intelligent Living Inc. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
Contact:
Gabriel Rodriguez
E Relations Group
888-261-6537
Hi Trader53,
Hope you can help me out with some hypothetical questions... if VC loaded up for a run in near future, does the run usually occur? And if the company is not doing well, then would the VC unload and how can I tell if they unloaded? Thanks.
SAPX (2 EXPLOSIVE NEWS OUT!!!!!!!!!)
----------------------------------------------------
NEWS 1
http://ih.advfn.com/p.php?pid=nmona&article=59569472
----------------------------------------------------
Schism Premiere to be Held During Screamfest
LOS ANGELES, Oct. 11, 2013 /PRNewswire/ -- Seven Arts Entertainment Inc. (OTCQB: SAPX) ("Seven Arts" or the "Company") is pleased to announce that its film "Schism" will premiere during Screamfest, L.A. The first screening will take place on Saturday 12th October; the film will also be screened at the prestigious New Orleans Film Festival on both Saturday 12th and Monday 14th October.
Director Adam Gierasch stated, "It's absolutely wonderful that Seven Arts gave me the opportunity to make my weird horror art noir film…my most personal movie to date, I really let me freak flag fly and I'm thrilled that it'll be premiering at Screamfest."
Schism tells the story of Dylan White; Dylan has a normal, boring life. Then horrifying visions start to interrupt his waking moments, and he must face the fact that he literally doesn't know who he is. Following clues that take him to the dark underbelly, Dylan soon finds both his life and soul in danger. Featuring a masterful performance by Callum Blue, SCHISM is a trip to the dark side, noir-style: bad men, bad dames, bad sex and bad intentions.
About Seven Arts Entertainment Inc.:
Seven Arts Entertainment Inc. was founded in 2002 as an independent motion picture production and distribution company engaged in the development, acquisition, financing, production and licensing of theatrical motion pictures for exhibition in domestic (i.e., the United States and Canada) and foreign theatrical markets, and for subsequent worldwide release in other forms of media, including home video and pay and free television.
Cautionary Information Regarding Forward-Looking Statements.
Forward-looking statements contained in this press release are made under the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated. The information contained in this release is as of October 10, 2013. Seven Arts assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.
Contact:
Seven Arts Entertainment Inc.
Peter Hoffman
(323) 372-3080
phoffman@7artspictures.com
SOURCE Seven Arts Entertainment Inc.
Copyright 2013 PR Newswire
----------------------------------------------------
NEWS 2
http://ih.advfn.com/p.php?pid=nmona&article=59569503
----------------------------------------------------
French Quarter Film House To Host Welcome Party For Film Makers At The New Orleans Film Festival
LOS ANGELES, Oct. 11, 2013 /PRNewswire/ -- Seven Arts Entertainment Inc. (OTCQB: SAPX) ("Seven Arts" or the "Company") is delighted to announce that its post-production facility the French Quarter Film House ("FQFH") located at 807 Esplanade Avenue, New Orleans will be hosting the prestigious Film Makers Welcome Party as part of the 2013 New Orleans Film Festival.
The event will be held on Friday 11th October, 10pm-1am.
This special VIP gathering celebrates the incredible work done by the 2013 class of 200+ filmmakers being shown across the festival from October 10th -17th.
The party is open to all-access Film Festival pass-holders and members of the media only. For media access please RSVP to Tyler Heath at 225-773-3874.
FQFH and Seven Arts are also thrilled to be sponsors of New Orleans Film Festival.
About the French Quarter Film House
Cutting edge technology meets historical splendor at FQFH, where a Greek Revival Whann-Bohn mansion conceived in 1859 has been completely and sympathetically rebuild and refurbished to house a much-needed post-production facility for the booming film production population in New Orleans. The unique facility offers state- of- the- art - sound studios, editing rooms, and screening areas and also serves as a luxurious residence for directors, producers, editors and technicians. FQFH is operated through the previously announced joint venture with Sixteen19.
About Seven Arts Entertainment Inc.:
Seven Arts Entertainment Inc. was founded in 2002 as an independent motion picture production and distribution company engaged in the development, acquisition, financing, production and licensing of theatrical motion pictures for exhibition in domestic (i.e., the United States and Canada) and foreign theatrical markets, and for subsequent worldwide release in other forms of media, including home video and pay and free television.
About Sixteen19
Sixteen19 is a global production services company specializing in digitally acquired productions. They have offices in New York, London and Los Angeles. Their creative division has won 10 Emmy Awards for commercial and promotional editorial. They have worked on such movies as "The Perks of being a Wallflower", "Taken 2" and "Twilight: Breaking Dawn Part 2
Cautionary Information Regarding Forward-Looking Statements.
Forward-looking statements contained in this press release are made under the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated. The information contained in this release is as of October 10, 2013. Seven Arts assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.
Contact:
Seven Arts Entertainment Inc.
Peter Hoffman
(323) 372-3080
phoffman@7artspictures.com
SOURCE Seven Arts Entertainment Inc.
Copyright 2013 PR Newswire
SAPX (2 EXPLOSIVE NEWS OUT!!!!!!!!!)
----------------------------------------------------
NEWS 1
http://ih.advfn.com/p.php?pid=nmona&article=59569472
----------------------------------------------------
Schism Premiere to be Held During Screamfest
LOS ANGELES, Oct. 11, 2013 /PRNewswire/ -- Seven Arts Entertainment Inc. (OTCQB: SAPX) ("Seven Arts" or the "Company") is pleased to announce that its film "Schism" will premiere during Screamfest, L.A. The first screening will take place on Saturday 12th October; the film will also be screened at the prestigious New Orleans Film Festival on both Saturday 12th and Monday 14th October.
Director Adam Gierasch stated, "It's absolutely wonderful that Seven Arts gave me the opportunity to make my weird horror art noir film…my most personal movie to date, I really let me freak flag fly and I'm thrilled that it'll be premiering at Screamfest."
Schism tells the story of Dylan White; Dylan has a normal, boring life. Then horrifying visions start to interrupt his waking moments, and he must face the fact that he literally doesn't know who he is. Following clues that take him to the dark underbelly, Dylan soon finds both his life and soul in danger. Featuring a masterful performance by Callum Blue, SCHISM is a trip to the dark side, noir-style: bad men, bad dames, bad sex and bad intentions.
About Seven Arts Entertainment Inc.:
Seven Arts Entertainment Inc. was founded in 2002 as an independent motion picture production and distribution company engaged in the development, acquisition, financing, production and licensing of theatrical motion pictures for exhibition in domestic (i.e., the United States and Canada) and foreign theatrical markets, and for subsequent worldwide release in other forms of media, including home video and pay and free television.
Cautionary Information Regarding Forward-Looking Statements.
Forward-looking statements contained in this press release are made under the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated. The information contained in this release is as of October 10, 2013. Seven Arts assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.
Contact:
Seven Arts Entertainment Inc.
Peter Hoffman
(323) 372-3080
phoffman@7artspictures.com
SOURCE Seven Arts Entertainment Inc.
Copyright 2013 PR Newswire
----------------------------------------------------
NEWS 2
http://ih.advfn.com/p.php?pid=nmona&article=59569503
----------------------------------------------------
French Quarter Film House To Host Welcome Party For Film Makers At The New Orleans Film Festival
LOS ANGELES, Oct. 11, 2013 /PRNewswire/ -- Seven Arts Entertainment Inc. (OTCQB: SAPX) ("Seven Arts" or the "Company") is delighted to announce that its post-production facility the French Quarter Film House ("FQFH") located at 807 Esplanade Avenue, New Orleans will be hosting the prestigious Film Makers Welcome Party as part of the 2013 New Orleans Film Festival.
The event will be held on Friday 11th October, 10pm-1am.
This special VIP gathering celebrates the incredible work done by the 2013 class of 200+ filmmakers being shown across the festival from October 10th -17th.
The party is open to all-access Film Festival pass-holders and members of the media only. For media access please RSVP to Tyler Heath at 225-773-3874.
FQFH and Seven Arts are also thrilled to be sponsors of New Orleans Film Festival.
About the French Quarter Film House
Cutting edge technology meets historical splendor at FQFH, where a Greek Revival Whann-Bohn mansion conceived in 1859 has been completely and sympathetically rebuild and refurbished to house a much-needed post-production facility for the booming film production population in New Orleans. The unique facility offers state- of- the- art - sound studios, editing rooms, and screening areas and also serves as a luxurious residence for directors, producers, editors and technicians. FQFH is operated through the previously announced joint venture with Sixteen19.
About Seven Arts Entertainment Inc.:
Seven Arts Entertainment Inc. was founded in 2002 as an independent motion picture production and distribution company engaged in the development, acquisition, financing, production and licensing of theatrical motion pictures for exhibition in domestic (i.e., the United States and Canada) and foreign theatrical markets, and for subsequent worldwide release in other forms of media, including home video and pay and free television.
About Sixteen19
Sixteen19 is a global production services company specializing in digitally acquired productions. They have offices in New York, London and Los Angeles. Their creative division has won 10 Emmy Awards for commercial and promotional editorial. They have worked on such movies as "The Perks of being a Wallflower", "Taken 2" and "Twilight: Breaking Dawn Part 2
Cautionary Information Regarding Forward-Looking Statements.
Forward-looking statements contained in this press release are made under the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated. The information contained in this release is as of October 10, 2013. Seven Arts assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.
Contact:
Seven Arts Entertainment Inc.
Peter Hoffman
(323) 372-3080
phoffman@7artspictures.com
SOURCE Seven Arts Entertainment Inc.
Copyright 2013 PR Newswire
EAPH heading back up!
EAPH NEWS out yesterday!
Easton Pharmaceuticals Re- Enters Drug Market, Acquires 50% Ownership Interest In FSAD Drug And Related Patents / Patent Pend...
Easton Pharmaceuticals (OTC: EAPH - News), a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products announces It has re-entered the drug market by acquiring a 50 percent ownership interest in a Drug designed to treat (FSAD) Female Sexual Arousal Disorder (FSAD). The acquisition terms are for the issuance of 10,000,000 restricted shares of the company’s common stock, previously issued in escrow and an option to purchase additional shares should the drug be developed and brought to a certain stage utilizing FDA protocols.
The Drug, whose name is not being disclosed at this point in time, is a topical Drug that consists of Alprostadil as its main ingredient. The acquisition includes a proprietary delivery system technology encompassing the use of “HA” Hyulronic Acid. The other 50 percent ownership interest of the Drug is owned by a private Canadian Pharmaceutical Company who’s name at this point is also being kept private. Easton Pharmaceuticals will need to develop a co-operative collaborating relationship for any additional progress to be made with the Drug. Included with the acquisition of the Drug designed to treat FSAD are certain patents / patent pendings filed in the United States patent office, Canada and in Europe, which includes a transdermal delivery technology which are presently not being used in any of Easton’s current product lines. Additional updates on this Drug including disclosing full product name, its patents / patent pendings and future plans will be made available in subsequent press releases and on its updated website to be shortly brought online.
In addition to some initial preliminary studies performed and positive data received, in 2007 and early 2008 the FSAD Drug underwent clinical trials using FDA protocols at Cedars-Sinai Medical Center, located in Beverley Hills, CA. The clinical study was not completed in its entirety and was ended prematurely due to various reasons, none of which were known to be related to any efficacy or safety issues.
The FSAD Drug is a water soluble, non-irritating, gel that is applied directly to the external female genitalia and uses a transdermal delivery system to deliver Alprostadil (0.08%), also known as prostaglandin E1, into the tissue. Alprostadil is a well known vasodilator that has been shown to induce vulvar and clitoral engorgement, increase vulvar erythema and edema, which indicates increased blood flow to the genital area. In preliminary studies, the Drug gel was shown to positively affect sexual arousal and pleasure in a dose dependent manner. Presently there are no products approved by the FDA to treat FSAD, but a similar type product is presently under clinical trials, but using its own proprietary delivery system.
John Adams, CEO of Easton Pharmaceuticals commented, “ After lengthy discussions, we are pleased to have finally come to terms and close on the acquisition of this drug which has shown promise in preliminary testing. Although the company must develop a collaborative joint effort with the other 50 percent owner of the Drug who’s name is currently being kept private, we believe both companies can assist each other to allow the Drug to be brought to a different stage in development including re-initiating clinical trials.” Mr. Adams further commented, “Although we have made the decision to acquire and re-enter into the drug industry as a treatment for FSAD, this does not in any way signify that it is deviating away from developing and bringing to market its “Viorra” product, which is not being classified as a drug requiring time consuming FDA clinical trials for the treatment of FSAD. We believe “Viorra” can be a safe and effective way to help treat the condition of FSAD for certain individuals looking to avoid precarious treatments and side effects.”
About Easton Pharmaceuticals Inc
Easton Pharmaceuticals is a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered drugs and therapeutic healthcare products, focused on skin and circulatory conditions that impact a large and expanding number of consumers including health issues related to female and male sexual dysfunction, treatment of certain pain, wound healing, scar and stretch marks, cellulite and varicose veins, the world market for these conditions is in excess of $10 billion.
The company's updated gel formulation is an innovative and thought to be unique transdermal delivery system. Easton Pharmaceuticals’ flagship product, VIORRA, is an over-the-counter aid for the treatment to restore and improve vaginal moisture and elasticity which has a very positive effect on women’s sexual desire and arousal, FSAD (Female Sexual Arousal Disorder) the world market for these female conditions are in excess of $2 billion. VIORRA is a topical, daily-use product classified by the FDA as containing Generally Recognized as Safe ingredients.
For More Information Visit
http://www.eastonpharma.com http://www.ashleybiomedical.com
Safe Harbor
This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding of discussion, the words "pleased," "plan," "confident that," "believe," "expect," or "intent to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing and other risks and uncertainties as stated in the company's financial reports and filings.
http://ih.advfn.com/p.php?pid=nmona&article=59224142
EAPH NEWS out yesterday!
Easton Pharmaceuticals Re- Enters Drug Market, Acquires 50% Ownership Interest In FSAD Drug And Related Patents / Patent Pend...
http://ih.advfn.com/p.php?pid=nmona&article=59224142
EAPH chart is AMAZZZZZING
FNRC buying pressure is up. somethings brewing
I took a second look at VOIS chart indicators. MFI shows uptrend, as well as accumulation. The upward momentum hasn't decreased, but increased!
Power Hour - here we go!
VOIS showing signs of momentum in chart. this could be a great momo play in the coming days imo.
VOIS now #33 on the breakout board!!!
FNRC is accumulating! Looks like it going to be a winner this week!
VOIS moved to #36 on the breakout board, up from #38 last night!!
VOIS #38 on the breakout board
VOIS still has HUGE HUGE potential. don't overlook the facts.
Hey people!! VOIS opened higher than yesterday's open & close, has higher high and higher low. If these are not good signs or signals, then I don't know what is. Chart still looks great! There's still a lot of accumulation, MACD is on the verge, ADX positive is still above the negative.
Look VOIS is a wonder according to the facts. don't let the dumpers scare you off!!!
VOIS at this price is a steal!!
WITH THE NEWS OUT, VFIN WILL SURELY BE OVERWHELMED WITH BUYERS AND SO WILL OTHER MMS
VFIN IS THIN!!! LOOK AT YOUR L2!!!!
Let's rally and give VOIS the momentum it deserves!!!
VOIS GOING TO PENNIES SOON!! NEWS ALREADY OUT!!
http://www.kctv5.com/story/22116818/vois-inc-announces-asset-acquisition-of-mind-technologies-inc
SOURCE VOIS, INC.
SAN DIEGO, April 30, 2013 /PRNewswire/ -- VOIS, INC. (OTCQB- VOIS) announces that it has acquired 100% of the assets of Mind Technologies, Inc. (MTEK) for the purpose of securing ownership of all of MTEK's BCI/ thought-controlled technology, and has assumed all of its liabilities.
In exchange for the sale of its assets, the Company will issue to MTEK 30,000,000 shares of its restricted common stock. The number of shares issuable to MTEK is based on a valuation of MTEK's assets performed by an independent accounting firm to determine the fair market value of the assets purchased. A definitive purchase agreement has been executed by both Companies.
As a result of the MTEK acquisition, VOIS now owns three completed thought-controlled software applications that are available on the market. VOIS also has completed a functioning prototype of a micro EEG headset, developed for the mobile market. The Company is in the process of securing adequate funding to complete the design and operating software system for the patent pending device.
Check out VOIS!! Up 12.50% + may go to pennies this week!! News just out!!
http://www.kctv5.com/story/22116818/vois-inc-announces-asset-acquisition-of-mind-technologies-inc
SOURCE VOIS, INC.
SAN DIEGO, April 30, 2013 /PRNewswire/ -- VOIS, INC. (OTCQB- VOIS) announces that it has acquired 100% of the assets of Mind Technologies, Inc. (MTEK) for the purpose of securing ownership of all of MTEK's BCI/ thought-controlled technology, and has assumed all of its liabilities.
In exchange for the sale of its assets, the Company will issue to MTEK 30,000,000 shares of its restricted common stock. The number of shares issuable to MTEK is based on a valuation of MTEK's assets performed by an independent accounting firm to determine the fair market value of the assets purchased. A definitive purchase agreement has been executed by both Companies.
As a result of the MTEK acquisition, VOIS now owns three completed thought-controlled software applications that are available on the market. VOIS also has completed a functioning prototype of a micro EEG headset, developed for the mobile market. The Company is in the process of securing adequate funding to complete the design and operating software system for the patent pending device.
Take a look @ VOIS, up 9.38%!!
with news this morning!!
http://www.kctv5.com/story/22116818/vois-inc-announces-asset-acquisition-of-mind-technologies-inc
VOIS News!! Gonna be a good week!!
http://www.kctv5.com/story/22116818/vois-inc-announces-asset-acquisition-of-mind-technologies-inc
FNRC trading higher @ .0038!! A good positive sign!!
FNRC cheapie price @ .0038, get'm while they last!!
FNRC website is http://1stnrg-corp.com
no cherry truffles there
Can't wait for the upcoming week! FNRC will be a nice ride up imo!!!
shares selling at .0038! I'd grab more but I'm all out.
The suspense is killing me. This may be the pennyland ride to remember.
you bet I am!
NITE is getting in on the action
FNRC LAST TRADE @.0044
FNRC UP 16.67%
FASTEN YOUR SEATBELTS LADIES AND GENTS!!
FNRC gaining momo!!
ASK IS NOW HITTING AT .0036!!!!